US › Healthcare

Claritev Corporation (CTEV)

US · Healthcare · Health Information Services

$26.40+8.69%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$244.7M
Revenue YoY
+5.8%
Net profit
$-73.6M
Profit YoY
-3.1%
EPS
$-3.30
EPS estimate
$1.38
Net margin
-30.1%

EPS came in at -3.30 against a street estimate of 1.38 — a miss of 339.1%.

Key statistics

Market cap
$387.2M
Forward P/E
4.1
P/B
0.23
Book value
$-14.18
EPS (TTM)
$-17.33
52-week high
$74.07
52-week low
$11.50
50-day MA
$28.14
200-day MA
$31.42
Beta
0.70

Analyst view

Analysts rate Claritev Corporation a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $37.67.

Shareholding

Insiders
7.45%
Institutions
91.03%

Largest institutional holders

FundStake
H&F Corporate Investors VIII, Ltd.22.81%
Ares Management LLC10.93%
Arini Captial Management Ltd9.00%
PUBLIC INVESTMENT FUND7.52%
Beach Point Capital Management LP4.52%
BlackRock Inc3.45%
CPV Partners, LLC2.91%
Vanguard Capital Management, LLC2.52%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Claritev Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.